Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: JNPR stock price vs OSCR: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at OSCR's multiple
Needs OSCR P/E.
Implied fair value · at JNPR's multiple
Needs Annual EPS is negative, JNPR P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
JUNIPER NETWORKS, INC. · implied price per share
Bear
$16.15
Base
$19.35
Bull
$23.51
Oscar Health, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CISCO SYSTEMS, INC.
JNPR vs CSCO
Dell Technologies Inc.
JNPR vs DELL
Palo Alto Networks Inc
JNPR vs PANW
Fortinet, Inc.
JNPR vs FTNT
VERISIGN INC/CA
JNPR vs VRSN
Match Group, Inc.
JNPR vs MTCH
Cigna Group
JNPR vs CI
CENTENE CORP
JNPR vs CNC
Elevance Health, Inc.
JNPR vs ELV
HUMANA INC
JNPR vs HUM
UNITEDHEALTH GROUP INC
JNPR vs UNH
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe JNPR can re-accelerate revenue growth from -8.8% while sustaining its 58.8% gross margin and 5.8% operating margin, then JNPR looks worth holding or adding because the implied price of $10.66 sits within the DCF range and below OSCR implied value.
The valuation framework suggests an implied price of $10.66 for JNPR versus a OSCR-implied range of $12.07 to $12.07 and a DCF range of $8.86 to $11.98. That places the implied price near the middle-to-lower end of the DCF band and below OSCR implied point, but the lack of a current JNPR price makes the actual discount or premium impossible to verify.
Supporting Metrics
